Production Method 1

73-22-3

103986-22-7

120-72-9

771-50-6

771-51-7

87-51-4

487-89-8

879-37-8

75833-70-4

Reaction Conditions

1.1 Reagents: Oxygen Solvents: Water ;  20 min, pH 7.8, 37 °C
1.2 Reagents: Hydrochloric acid Solvents: Water

Reference

Production of indole-3-acetic acid and related indole derivatives from L-tryptophan by Rubrivivax benzoatilyticus JA2

Mujahid, Md.; et al, Applied Microbiology and Biotechnology, 2011, 89(4), 1001-1008

2-(6-Methoxy-1H-indol-3-yl)acetic Acid Raw materials

• L-Tryptophan

2-(6-Methoxy-1H-indol-3-yl)acetic Acid Preparation Products

• Indole (120-72-9)
• 1H-indole-3-carboxylic acid (771-50-6)
• 2-(1H-indol-3-yl)acetonitrile (771-51-7)
• 3-Indoleacetic acid (87-51-4)
• Indole-3-carboxaldehyde (487-89-8)
• 2-(1H-indol-3-yl)acetamide (879-37-8)
• 1H,1''H-3,3':3',3''-terindol-2'(1'H)-one (75833-70-4)
• 2-(6-Methoxy-1H-indol-3-yl)acetic Acid (103986-22-7)

• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indole-3-acetic acid derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolyl carboxylic acids and derivatives Indole-3-acetic acid derivatives

Introduction to 2-(6-Methoxy-1H-indol-3-yl)acetic Acid (CAS No. 103986-22-7)

2-(6-Methoxy-1H-indol-3-yl)acetic Acid, identified by its CAS number 103986-22-7, is a significant compound in the realm of pharmaceutical chemistry and drug discovery. This molecule, featuring a combination of an indole moiety and an acetic acid side chain, has garnered considerable attention due to its structural features and potential biological activities. The presence of the 6-methoxy group and the indol-3-yl moiety contributes to its unique chemical properties, making it a valuable scaffold for developing novel therapeutic agents.

The indole ring is a well-documented pharmacophore in medicinal chemistry, known for its role in various biological processes and its incorporation into numerous bioactive molecules. The 6-methoxy substitution enhances the lipophilicity and electronic properties of the indole core, influencing its interactions with biological targets. When coupled with the acetic acid functionality, the compound exhibits both hydrophilic and hydrophobic characteristics, which can be advantageous for membrane permeability and binding affinity.

In recent years, there has been a surge in research focused on indole derivatives as potential therapeutic candidates. These compounds have shown promise in various disease models, including cancer, inflammation, and neurological disorders. The specific arrangement of functional groups in 2-(6-Methoxy-1H-indol-3-yl)acetic Acid positions it as a candidate for further exploration in these areas. Studies have begun to uncover its potential mechanisms of action, particularly in modulating signaling pathways associated with disease progression.

One of the most compelling aspects of this compound is its ability to interact with multiple biological targets. The indole core can engage with transcription factors, while the acetic acid side chain may influence receptor binding or enzyme inhibition. Such multifaceted interactions make 2-(6-Methoxy-1H-indol-3-yl)acetic Acid a promising lead for structure-based drug design. Researchers are leveraging computational methods to predict how modifications to this scaffold could enhance its efficacy and selectivity.

Recent experimental studies have provided insights into the pharmacological profile of 2-(6-Methoxy-1H-indol-3-yl)acetic Acid. In vitro assays have demonstrated its ability to inhibit certain kinases and modulate cytokine production, suggesting potential applications in anti-inflammatory therapies. Additionally, preliminary in vivo studies indicate that this compound can attenuate tumor growth in animal models by disrupting key oncogenic pathways. These findings underscore the importance of further investigating this molecule for therapeutic development.

The synthesis of 2-(6-Methoxy-1H-indol-3-yl)acetic Acid is another area of active interest. Chemists have developed several synthetic routes to access this compound efficiently, with particular focus on optimizing yield and purity. Advances in catalytic methods have enabled more sustainable production processes, aligning with the growing emphasis on green chemistry principles in pharmaceutical manufacturing. These synthetic strategies not only facilitate research but also pave the way for large-scale production if clinical efficacy is demonstrated.

As research progresses, 2-(6-Methoxy-1H-indol-3-yl)acetic Acid is poised to become a key player in drug discovery efforts. Its unique structural features and demonstrated biological activity make it a compelling candidate for further development. Collaborative efforts between academic researchers and industry scientists are essential to translate these findings into tangible therapeutic benefits. By combining experimental data with innovative computational approaches, the full potential of this compound can be realized.

The future directions for studying 2-(6-Methoxy-1H-indol-3-yl)acetic Acid include exploring its role in complex disease pathways and optimizing its pharmacokinetic properties. Investigating how this molecule interacts with other drugs or environmental factors will also provide valuable insights into its clinical utility. As our understanding of molecular mechanisms continues to evolve, compounds like 2-(6-Methoxy-1H-indol-3-yl)acetic Acid will serve as critical tools for unraveling disease processes and developing novel treatments.

In conclusion, 2-(6-Methoxy-1H-indol-3-yl)acetic Acid (CAS No. 103986-22-7) represents a significant advancement in pharmaceutical chemistry. Its unique structure, combined with promising biological activities, positions it as a valuable asset in the quest for new therapeutics. Ongoing research efforts are expected to yield further insights into its potential applications, reinforcing its importance as a compound worthy of continued investigation.

• 54-16-0(2-(5-hydroxy-1H-indol-3-yl)acetic acid)
• 4382-53-0(2-[5-(benzyloxy)-1H-indol-3-yl]acetic acid)
• 682802-82-0(2-[6-(benzyloxy)-1H-indol-3-yl]acetic acid)
• 3471-31-6(2-(5-Methoxy-1H-indol-3-yl)acetic acid)
• 1321-73-9(5-hydroxyindole-3-acetic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)